Montpellier, France

Alexandre Prieur

USPTO Granted Patents = 10 

 

 

Average Co-Inventor Count = 1.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2016-2024

Loading Chart...
Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Alexandre Prieur

Introduction

Alexandre Prieur is a notable inventor based in Montpellier, France, recognized for his contributions to medical science, particularly in cancer treatment. With an impressive portfolio of 10 patents, Prieur has dedicated his career to innovative approaches in oncology and diagnostics, showcasing the intersection of biotechnology and patient care.

Latest Patents

Prieur's latest patents reflect a significant advancement in cancer therapies. One of his notable inventions is the combination therapy involving anti-progastrin monoclonal antibodies and immunotherapy, aimed at treating various forms of cancer. This patent outlines compositions that combine these therapeutic agents alongside methods for utilizing them in clinical settings.

Another key invention pertains to the detection of lung cancer. This patent introduces methods for the in vitro diagnosis of lung cancer by detecting progastrin through specific progastrin-binding antibodies. This innovative approach aims to enhance early diagnosis, offering better prognoses for patients by identifying lung cancer markers effectively.

Career Highlights

Throughout his career, Alexandre Prieur has made impactful strides in the field of cancer research. He has worked with prominent institutions, including Progastrine Et Cancers S.À R.L. and Université de Montpellier. These experiences have not only contributed to his development as an inventor but have also positioned him at the forefront of cutting-edge research in oncological therapies.

Collaborations

Prieur's journey has been enriched by collaborating with esteemed professionals in the field. Notable coworkers include Ollivier Milhavet and Jean-Marc Lemaitre, who have partnered with him on various projects aimed at advancing cancer treatment and diagnostics. Together, they have contributed to a collaborative environment that fosters innovation and produces significant breakthroughs in medical science.

Conclusion

In conclusion, Alexandre Prieur stands out as a dedicated inventor whose work holds promise for transforming cancer therapies and diagnostic methods. His innovative patents reflect a commitment to improving patient outcomes and expanding the scientific understanding of cancer treatment, solidifying his role as a key contributor to the future of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…